1Hussain SA,James ND.The systemic treatment of advanced and metastatic bladder cancer.Lancet Oncol,2003,4,489～97
2Bellmunt J,de Wit R,Albiol S,et al.New drugs and new approaches in metastatic bladder cancer.Crit Rev Oncol Hematol,2003,47(2),195～206
3Raghavan D.Advanced bladder and urothelial cancers.Eur J Cancer,2000,36 Suppl 2,1～6
4Culine S.The present and future of combination chemotherapy in bladder cancer.Semin Oncol,2002,29(3 Suppl 9),32～9
5von der Maase H.Current and future perspectives in advanced bladder cancer:is there a new standard.Semin Oncol,2002,29(1suppl 3),3～14
6Saxman SB,Propert KJ,Einhorn LH,et al.Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate,vinblastine,and doxorubicin in patients with metastatic urothelial carcinoma:a cooperative group study.J Clin Oncol,1997,15(7),2564～9
7Roth BJ,Dreicer R,Einhorn LH,et al.Significant activity of paclitaxel in advanced transitional cell carcinoma of the urothelium:a phase II trial of the Eastern Cooperative Oncology Group(E1892).J Clin Oncol,1994,12(11),2264～70
8de Wit R,Kruit WH,Stoter G,et al.Docetaxel(Taxotere):an active agent in metastatic urothelial cancer;results of a phase II study in non-chemotherapy-pretreated patients.Br J Cancer,1998,78(10),1342～5
9Pollera CF,Ceribelli A,Grecco M,et al.Weekly gemcitabine in advanced bladder cancer.A preliminary report from a phase I study.Ann Oncol,1994,5(2),182～4
10Witte RS,Elson P,Bono B,et al.Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma.J Clin Oncol,1997,15(2),589～93
同被引文献16
1Hussain SA,James ND.The systemic treatment of advanced and metastatic bladder cancer[J].Lancet Oncol,2003,4:489-497.
2Shrod SS,Faucette SR,Gillenwater HH,et al.Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with dvanced non-small-cell lung cancer[J].Cancer Chemother Pharmacol,2003,51:328.
3Khaled HM,Zaqhloul MS,Ghoneim M,et al.A randomized phase Ⅲ study of neoadjuvant chemotherapy for invasive bladder cancer with gemcitabine and cisplatin[J].Proc Ann Meet Am Soc Clin Oncol,2002,21:A2421.
4周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2002.45～48.
5Inoue K,Kasahara K,Imoue Y,et al.The drricacy of ATP sensitivity assay on intravesical prophylactic instillation for superficial bladder cancer[J].Nippon Hinyokika Gakkai Zasshi,1996,87(12):1281-1288.
6W Kassouf,D Swanson,AM Kamat.Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. Journal d Urologie . 2006
7Stacy S. Shord,Stephanie R. Faucette,Heidi H. Gillenwater,Scott L. Pescatore,Roy L. Hawke,Mark A. Socinski,Celeste Lindley.Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer[J]. Cancer Chemotherapy and Pharmacology . 2003 (4)
9Smaldone MC,Jacobs BL,Smaldone AM,et al.Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma. Urology . 2008
10Khaled HM,Zaqhloul MS,Ghoneim M,et al.A random-ized phaseⅢstudy of neoadjuvant chemotherapy for inva-sive bladder cancer with gemcitabine and cisplatin. Proceedings of the American Society of Clinical Oncology . 2005
